U.S. markets closed

Epigenomics AG (EPGNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.0800+0.2800 (+10.00%)
At close: 3:25PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 2/20/2021
Current
9/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
17.31M135.57M74.74M52.33M66.56M
Enterprise Value 3
10.18M126.44M63.36M46.48M60.61M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
2.0916.606.284.966.20
Price/Book (mrq)
2.561.981.380.700.87
Enterprise Value/Revenue 3
12.43577.37763.38194.47218.04
Enterprise Value/EBITDA 6
-0.82-48.48-19.70-16.47-16.39

Trading Information

Stock Price History

Beta (5Y Monthly) 1.13
52-Week Change 3113.89%
S&P500 52-Week Change 323.92%
52 Week High 36.8400
52 Week Low 30.4400
50-Day Moving Average 33.5279
200-Day Moving Average 32.6913

Share Statistics

Avg Vol (3 month) 31.74k
Avg Vol (10 day) 31.79k
Shares Outstanding 55.89M
Float 3.11M
% Held by Insiders 117.47%
% Held by Institutions 128.42%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-76.52%
Return on Equity (ttm)-222.81%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)30.40%
Gross Profit (ttm)872k
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.6670
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)13.42
Current Ratio (mrq)2.70
Book Value Per Share (mrq)0.51

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A